RxDoctor Payments Data

Nicole Peterson, APRN

Family · Omaha, NENPI 1710756069

Payments from drug & device makers

$1,710in general payments, 2019–2025

Across 93 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$371
  • Lilly USA, LLC$177
  • Vifor Pharma, Inc.$176
  • Calliditas Therapeutics US Inc.$154
  • Mallinckrodt Hospital Products Inc.$127
  • Travere Therapeutics, Inc.$116
  • plus $588 from 12 others

What the payments were for

  • Food & beverage$1,67198%
  • Education$392%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,710 in reported general payments places this provider in the 80th percentile of 809 family providers in Nebraska.

See all family providers in Nebraska

Medicare billing

Part B allowed, 2024
$22,511
Medicare patients
191
Services billed
349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
KerendiaFinerenone24$15,810
JardianceEmpagliflozin13$7,411
Midodrine Hcl11$1,099
Calcitriol36$446
Bumetanide11$377
Torsemide16$281
Hydralazine Hcl16$272
Lisinopril56$237
Losartan Potassium32$233
Furosemide70$198
Amlodipine Besylate27$134
Potassium Chloride12$68

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
BayerKerendia$371$15,81024 claims
Boehringer IngelheimJardiance$71$7,41113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 809 family providers in Nebraska.

Other family in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →